Insider Trading & Ownership of STEVE ASELAGE

Location: Fremont, CA
Summary: The estimated net worth of STEVE ASELAGE is at least $2,375,935 dollars as of 14 Jun 2024. STEVE ASELAGE is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $1.32M. STEVE ASELAGE is the Director of Acer Therapeutics Inc. and owns shares of Acer Therapeutics Inc. stock worth about $590.2K. STEVE ASELAGE is the Director of BIOCRYST PHARMACEUTICALS INC and owns shares of BIOCRYST PHARMACEUTICALS INC (BCRX) stock worth about $469.4K.
Signature: /s/ Alane P. Barnes, by power of attorney
All Insider Reports: All Insider Reports

Notify me when STEVE ASELAGE files a new Insider Trading report.

Ownership of STEVE ASELAGE

Symbol	Company	Relationship	Holdings Value	Report Period
TVTX	Travere Therapeutics, Inc.	Director	$1,316,394	11 May 2022
ACER	Acer Therapeutics Inc.	Director	$590,164	17 Nov 2023
BCRX	BIOCRYST PHARMACEUTICALS INC	Director	$469,377	12 Jun 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.